Novel GLP-1 secretagogues as neuroprotective agents for retinal neurodegenerative diseases

被引：0
|
作者：
Powell, Folami Lamoke [1 ]
Thomas, Shakera [2 ]
Martin, Pamela M. [1 ]
机构：
[1] Augusta Univ, Biochem & Mol Biol, Med Coll Georgia, Augusta, GA USA
[2] Morehouse Sch Med, Atlanta, GA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases
    Calsolaro, Valeria
    Edison, Paul
    CNS DRUGS, 2015, 29 (12) : 1023 - 1039
  • [22] Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia
    Zhang, Huinan
    Meng, Jingru
    Li, Xubo
    Zhou, Shimeng
    Qu, Di
    Wang, Ning
    Jia, Min
    Ma, Xue
    Luo, Xiaoxing
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 : 82 - 91
  • [23] Adenosine triphosphate maintenance by branched chain amino acids as a novel neuroprotective strategy for retinal neurodegenerative diseases
    Hasegawa, Tomoko
    Ikeda, Hanako Ohashi
    NEURAL REGENERATION RESEARCH, 2019, 14 (01) : 82 - 84
  • [24] Adenosine triphosphate maintenance by branched chain amino acids as a novel neuroprotective strategy for retinal neurodegenerative diseases
    Tomoko Hasegawa
    Hanako Ohashi Ikeda
    NeuralRegenerationResearch, 2019, 14 (01) : 82 - 84
  • [25] Editorial: Novel frontiers of retinal neurodegenerative diseases
    Li, Wensheng
    Zheng, Qinxiang
    Chen, Bo
    Tzekov, Radouil
    FRONTIERS IN MEDICINE, 2024, 11
  • [26] ZY-GLP1: A NOVEL PEPTIDOMIMETICS GLP-1 AGONIST
    Bahekar, R.
    Joharapurkar, A.
    Bandyopadhyaya, D.
    Chakraborty, G.
    Patel, H.
    Pawar, V.
    Sunder, R.
    Jain, M.
    Patel, P.
    BIOPOLYMERS, 2009, 92 (04) : 307 - 307
  • [27] Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
    Wang, Qinghua
    Chen, Kui
    Liu, Rui
    Zhao, Fang
    Gupta, Sandeep
    Zhang, Nina
    Prud'homme, Gerald J.
    PLOS ONE, 2010, 5 (09): : 1 - 9
  • [28] Repurposing GLP1 agonists for neurodegenerative diseases
    Markaki, Ioanna
    Winther, Kristian
    Catrina, Sergiu-Bogdan
    Svenningsson, Per
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: TREATING NEURODEGENERATIVE DISEASES AS METABOLIC DISEASES, 2020, 155 : 91 - 112
  • [29] Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative Disorders: A Large-Scale Propensity-Matched cohort study
    Siddeeque, Nabeela
    Hussein, Mohammad H.
    Abdelmaksoud, Ahmed
    Bishop, Julia
    Attia, Abdallah S.
    Elshazli, Rami M.
    Fawzy, Manal S.
    Toraih, Eman A.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [30] Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases
    Nakashima, Moeka
    Suga, Naoko
    Yoshikawa, Sayuri
    Matsuda, Satoru
    MOLECULES, 2024, 29 (16):
12345